Caris Life Sciences Affirms FY2026 Sales Guidance of $1.000B-$1.020B vs $1.007B Est

Benzinga Newsdesk www.benzinga.com Negative 66.7%

Neg 66.7% Neu 0% Pos 0%

Caris Life Sciences (NASDAQ:CAI) affirms FY2026 sales outlook from $1.000 billion-$1.020 billion to $1.000 billion-$1.020 billion vs $1.007 billion estimate.